Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance

Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance

Ting Li,1,&ast; Lianshan Guo,2,&ast; Jiaxu Li,3,&ast; Xingyu Mu,4 Lijuan Liu,1 Shulin Song,1 Ningbin Luo,1 Qi Zhang,5 Bin Zheng,1 Guanqiao Jin1 1Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People’s Republic of China; 2Department of Emergency, The...

Full description

Bibliographic Details
Main Authors:	Li T, Guo L, Li J, Mu X, Liu L, Song S, Luo N, Zhang Q, Zheng B, Jin G
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-02-01
Series:	International Journal of Nanomedicine
Subjects:	immunotherapy resistance immune checkpoint blockade nanotheranostic agent photothermal therapy enhancing efficacy
Online Access:	https://www.dovepress.com/precision-uspio-peg-slex-nanotheranostic-agent-targeted-photothermal-t-peer-reviewed-fulltext-article-IJN

Similar Items

Second near-infrared nanomaterials for cancer photothermal immunotherapy
by: Haojie Shang, et al.
Published: (2023-03-01)

Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer
by: Benchao Zheng, et al.
Published: (2025-04-01)

Advances in Photothermal and Photodynamic Nanotheranostics for Precision Cancer Treatment
by: Hossein Omidian, et al.
Published: (2024-12-01)

NIR-II Absorbing Conjugated Polymer Nanotheranostics for Thermal Initiated NO Enhanced Photothermal Therapy
by: Kaiwen Chang, et al.
Published: (2023-06-01)

Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
by: Qian Chen, et al.
Published: (2025-01-01)

Combining photothermal ablation-based vaccine with immune checkpoint blockade for synergistic osteosarcoma immunotherapy
by: Xingyu Zhao, et al.
Published: (2021-01-01)

An enzyme-responsive and transformable PD-L1 blocking peptide-photosensitizer conjugate enables efficient photothermal immunotherapy for breast cancer
by: Yanan Sun, et al.
Published: (2023-04-01)

Cancer Nanotheranostics
by: Kamolrat Thanapprapasr
Published: (2014-10-01)

Potentiating dual-directional immunometabolic regulation with nanomedicine to enhance anti-tumor immunotherapy following incomplete photothermal ablation
by: Qinqin Jiang, et al.
Published: (2024-06-01)

Photothermal therapies to improve immune checkpoint blockade for cancer
by: Preethi B. Balakrishnan, et al.
Published: (2020-12-01)

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy
by: Junyu Long, et al.
Published: (2017-08-01)

Vehicle-Free Nanotheranostic Self-Assembled from Clinically Approved Dyes for Cancer Fluorescence Imaging and Photothermal/Photodynamic Combinational Therapy
by: Mingbin Huang, et al.
Published: (2022-05-01)

The age of enlightenment in melanoma immunotherapy
by: Mark R. Albertini
Published: (2018-08-01)

Polyethylene glycol-coated ultrasmall superparamagnetic iron oxide nanoparticles-coupled sialyl Lewis X nanotheranostic platform for nasopharyngeal carcinoma imaging and photothermal therapy
by: Qinmin Liu, et al.
Published: (2021-06-01)

Emerging nitric oxide gas‐assisted cancer photothermal treatment
by: Shuang Liang, et al.
Published: (2024-12-01)

Biodegradable nanotheranostics with hyperthermia-induced bubble ability for ultrasound imaging–guided chemo-photothermal therapy
by: Xu C, et al.
Published: (2019-09-01)

Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
by: Amber J. Giles, et al.
Published: (2018-06-01)

Nanomaterial-Based Tumor Photothermal Immunotherapy
by: Xu P, et al.
Published: (2020-11-01)

Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy
by: Wang, Zhimin, et al.
Published: (2021)

Checkpoint nano-PROTACs for activatable cancer photo-immunotherapy
by: Zhang, Chi, et al.
Published: (2023)

A novel nanomedicine integrating ferroptosis and photothermal therapy, well-suitable for PD-L1-mediated immune checkpoint blockade
by: Yujun Bao, et al.
Published: (2024-12-01)

Nanotheranostic applications for detection and targeting neurodegenerative diseases
by: Kumar, Ajay, et al.
Published: (2021)

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy
by: Christian Sordo-Bahamonde, et al.
Published: (2023-08-01)

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
by: Pengfei Zhao, et al.
Published: (2019-05-01)

Editorial: Personalized immunotherapy for cancer
by: Anna Pasetto, et al.
Published: (2023-03-01)

Cancer immunotherapies: advances and bottlenecks
by: Rui Rui, et al.
Published: (2023-08-01)

Dendritic Cells and Their Role in Immunotherapy
by: Alycia Gardner, et al.
Published: (2020-05-01)

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy
by: Timothy V. Pham, et al.
Published: (2020-08-01)

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
by: Ariel E. Marciscano, et al.
Published: (2018-01-01)

Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy
by: Shaoyue Li, et al.
Published: (2022-04-01)

DNA-tethered Polymersome Clusters as Nanotheranostic Platform
by: Claire E. Meyer, et al.
Published: (2021-04-01)

Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
by: Zhihao Lu, et al.
Published: (2020-08-01)

Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors
by: Zhijia Xia, et al.
Published: (2023-07-01)

Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
by: Jing Jin, et al.
Published: (2020-05-01)

Progress in Neoantigen Targeted Cancer Immunotherapies
by: Xue-Jiao Han, et al.
Published: (2020-07-01)

Polarization of tumor-associated macrophages promoted by vitamin C-loaded liposomes for cancer immunotherapy
by: Ma, Zhaoyu, et al.
Published: (2023)

Basis for Immunotherapy for Treatment of Meningiomas
by: Tomas Garzon-Muvdi, et al.
Published: (2020-08-01)

Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
by: Jesse Haramati, et al.
Published: (2025-02-01)

Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer
by: Stephanie Dorta-Estremera, et al.
Published: (2019-09-01)

Role of DNA repair defects in predicting immunotherapy response
by: Jing Zhang, et al.
Published: (2020-06-01)